Articles

  1. Formulation Development Center (FDC) 6/1/2026

    Integrated formulation development and manufacturing support oral, injectable, and complex drugs, advancing from research to commercial production with quality, efficiency, and compliance.

  2. Mammalian Expression 5/28/2026

    See how a biotechnology company advanced an engineered protein therapeutic while navigating development, regulatory, and scalability challenges. 

  3. Sterilization Of APIs – The Alternative: Sterile Filtration Following Aseptic Processing 5/21/2026

    When terminal sterilization isn't an option for heat- or radiation-sensitive APIs, sterile filtration with aseptic processing protects quality. Get the technical framework.

  4. CDMO Services: Customized Lipids And LNP Solutions 5/21/2026

    This view of lipid and LNP development shows how experience, global GMP‑ready manufacturing, and flexible collaboration models support programs from preclinical through commercialization.

  5. Sterile Filtration Of Budesonide As A Preferred Sterilization Strategy 5/19/2026

    Accelerate development of high‑quality inhalation therapies by leveraging sterile‑filtered budesonide to safeguard purity, stability, and patient safety.

  6. Highly Potent Active Pharmaceutical Ingredients 5/19/2026

    Empower safer, faster development of complex therapeutics by partnering with an HPAPI‑focused CDMO that delivers proven containment, rigorous quality, and end‑to‑end expertis

  7. Fermentation Development And Manufacturing 5/19/2026

    Scale microbial fermentation from preclinical to 40,000 L GMP with integrated biocatalysis and downstream processing. Explore Curia's full capabilities.

  8. Viral Vector CDMO Services 5/18/2026

    Scale your viral vector program with confidence: 20+ years CGMP experience, 1,200+ GMP lots, and 3 approved products. Access full-service manufacturing from IND to commercial.

  9. Quality At Scale: Biologics Development And Manufacturing 5/18/2026

    886+ biologics batches. 12 commercial molecules. Proven scale-up from IND to commercialization. See how a global CDMO network protects quality at every stage.

  10. Accelerating Development Of A Unique Molecule To Treat Lung Cancer 5/14/2026

    Process development and optimization enabled efficient scale‑up of a complex lung cancer therapy, improving yields, reducing costs, and supporting rapid clinical and commercial progress.